
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & Podcasts
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! Paper: Landing Page: Substack:
E133: Obinutuzumab for SLE (ALLEGORY) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would lik...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Mar 19, 2026, 15:21 long, audio available.
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! Paper: Landing Page: Substack:
You can listen to E133: Obinutuzumab for SLE (ALLEGORY) online on Radio and Podcast. Open the player on this page to stream the available audio.
E133: Obinutuzumab for SLE (ALLEGORY) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 15:21 long.
This episode was published on Mar 19, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E133: Obinutuzumab for SLE (ALLEGORY) on this page when the episode audio is available from the podcast feed.
E133: Obinutuzumab for SLE (ALLEGORY) is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Mar 19, 2026 and 15:21 long